کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
6199347 | 1262395 | 2015 | 7 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
Intravitreal Ranibizumab for Diabetic Macular Edema with Prompt versus Deferred Laser Treatment: 5-Year Randomized Trial Results
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
کلمات کلیدی
موضوعات مرتبط
علوم پزشکی و سلامت
پزشکی و دندانپزشکی
چشم پزشکی
پیش نمایش صفحه اول مقاله
چکیده انگلیسی
Five-year results suggest focal/grid laser treatment at the initiation of intravitreal ranibizumab is no better than deferring laser treatment for â¥24 weeks in eyes with DME involving the central macula with vision impairment. Although more than half of eyes in which laser treatment is deferred may avoid laser for at least 5 years, such eyes may require more injections to achieve these results when following this protocol. Most eyes treated with ranibizumab and either prompt or deferred laser maintain vision gains obtained by the first year through 5 years with little additional treatment after 3 years.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Ophthalmology - Volume 122, Issue 2, February 2015, Pages 375-381
Journal: Ophthalmology - Volume 122, Issue 2, February 2015, Pages 375-381
نویسندگان
Michael J. MD, Allison MS, Neil M. MD, David MD, Christina J. MD, Adam R. MS, Lee M. MD, Thomas W. MD, Diabetic Retinopathy Clinical Research Network Diabetic Retinopathy Clinical Research Network,